投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
9.4 %
年文章数
2920
作者需知
暂无数据
NCBI查询
偏重的研究方向
期刊简介
稿件收录要求
稿件收录要求
Shock includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. There is no single journal, which encompasses the etiology, cellular and molecular mechanisms, and therapeutic approaches to the treatment of shock in a comprehensive and coherent manner, while still maintaining a clear focus on the pathobiology of shock. The journal is poised to meet the present and future needs of investigators involved in sophisticated basic and clinical studies of shock, trauma, sepsis, endotoxemia, ischemia/reperfusion, inflammation, and other related pathophysiologic states.
